FR1310459A - Procédé de préparation de -3-pyrrolidinols substitués - Google Patents

Procédé de préparation de -3-pyrrolidinols substitués

Info

Publication number
FR1310459A
FR1310459A FR818111A FR818111A FR1310459A FR 1310459 A FR1310459 A FR 1310459A FR 818111 A FR818111 A FR 818111A FR 818111 A FR818111 A FR 818111A FR 1310459 A FR1310459 A FR 1310459A
Authority
FR
France
Prior art keywords
pyrrolidinols
substituted
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR818111A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mead Johnson and Co LLC
Original Assignee
Mead Johnson and Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mead Johnson and Co LLC filed Critical Mead Johnson and Co LLC
Application granted granted Critical
Publication of FR1310459A publication Critical patent/FR1310459A/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12Oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J73/00Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J73/00Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/003Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by oxygen as hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
FR818111A 1959-02-12 1960-02-10 Procédé de préparation de -3-pyrrolidinols substitués Expired FR1310459A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79271259A 1959-02-12 1959-02-12
US2571A US3108117A (en) 1959-02-12 1960-01-15 3-benzyl-1, 2-diloweralkyl-3-pyrrolidinols

Publications (1)

Publication Number Publication Date
FR1310459A true FR1310459A (fr) 1962-11-30

Family

ID=26670565

Family Applications (1)

Application Number Title Priority Date Filing Date
FR818111A Expired FR1310459A (fr) 1959-02-12 1960-02-10 Procédé de préparation de -3-pyrrolidinols substitués

Country Status (6)

Country Link
US (1) US3108117A (fr)
BE (1) BE587542A (fr)
CH (1) CH419127A (fr)
DE (1) DE1445100A1 (fr)
FR (1) FR1310459A (fr)
GB (1) GB882813A (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5821622B2 (ja) * 1973-02-28 1983-05-02 ウェルファイド株式会社 ピロリジンメタノ−ル ノ セイゾウホウ
EP0586229A1 (fr) * 1992-09-01 1994-03-09 Zeneca Limited 3-Hydroxy-3-(akyl-subst.)-pyrrolidines comme inhibiteur de la 5-lipoxygénase
US7638541B2 (en) 2006-12-28 2009-12-29 Metabolex Inc. 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
AU2008279447A1 (en) 2007-07-19 2009-01-29 Metabolex, Inc. N-azacyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of the RUP3 or GPR119 receptor for the treatment of diabetes and metabolic disorders
CA2727174A1 (fr) * 2008-06-20 2010-01-21 Jiangao Song Agonistes des recepteurs gpr119 aryles et utilisations associees
ES2497566T3 (es) 2009-10-01 2014-09-23 Cymabay Therapeutics, Inc. Sales de tetrazol-1-il-fenoximetil-tiazol-2-il-piperidinil-pirimidina sustituida
EP2585048B1 (fr) 2010-06-23 2018-04-11 CymaBay Therapeutics, Inc. Compositions de 5-éthyl-2-{4-[4-(4-tétrazol-1-yl-phénoxyméthyl)-thiazol-2-yl]-pipéridin-1-yl}-pyrimidine
CN109862896A (zh) 2016-08-03 2019-06-07 西玛贝医药公司 用于治疗炎症性胃肠疾病或胃肠病症的氧亚甲基芳基化合物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2878264A (en) * 1959-03-17 Substituted amino alcohols

Also Published As

Publication number Publication date
US3108117A (en) 1963-10-22
GB882813A (en) 1961-11-22
DE1445100A1 (de) 1969-01-16
BE587542A (fr) 1960-08-12
CH419127A (de) 1966-08-31

Similar Documents

Publication Publication Date Title
CH395138A (fr) Procédé de préparation de 2-phénoxy-2-phényléthylamines
CH389622A (fr) Procédé de préparation de trifluoreméthyl-phényl-pipérazines
FR1310459A (fr) Procédé de préparation de -3-pyrrolidinols substitués
CH425807A (fr) Procédé de préparation de thiadiazines substituées
CH398573A (fr) Procédé de préparation de 2-cyano-3-oxo-stéroïdes
FR1458905A (fr) Procédé de préparation de 1-aralcoyl-4-arylpipérazines
BE588923A (fr) Procédé de préparation de phényltétrahydropyrylpipérazines.
FR1274416A (fr) Procédé de préparation de nouvelles aryloxyméthyl-2-oxazolidinones
CH394171A (fr) Procédé de préparation de stéroïdes
FR1273365A (fr) Procédé pour la préparation de pyridylméthylamines
FR1269067A (fr) Procédé de préparation de la benzoxazolone
FR1242850A (fr) Procédé de préparation de 3-monoalcoylamino 7-dialcoylamino n-alcoyl phénoxazimes-2
BE585056A (fr) Procédé de préparation de 1-amino-alcoyl-2-(arylamino-alcoyl)-benzimidazoles
FR1309821A (fr) Procédé de préparation de 3-amino-4-phényl-pyrazols
FR1261019A (fr) Procédé de préparation des dihydrobenzothiadiazines substituées
FR1393957A (fr) Procédé de préparation de nouvelles dihydroquinoxalones
FR1258501A (fr) Procédé de préparation de polyoléfines
FR1438157A (fr) Procédé de préparation de sulfonamides
FR1224139A (fr) Procédé de préparation de fluoro-hydroxy-stéroïdes
FR1402805A (fr) Procédé de préparation de 4-méthoxy-2-méthyl-6-sulfanilamidopyrimidine
FR1450357A (fr) Procédé de préparation de 6-fluoro-delta4-3-céto-stéroïdes
CH394186A (fr) Procédé de préparation de bis-hydroxyméthylène-prégnane
FR1244648A (fr) Procédé de préparation de p-nitro-diarylamines
FR1354758A (fr) Procédé de préparation de prégnadiènes substitués
CH400143A (fr) Procédé de préparation de cétostéroïdes substitués